Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octafibrin in children with congenital afibrinogenemia
IRCT2014112320051N3Phase 3Completed
- Sponsor
- Octapharma
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Fibrinogen human in congenital afibrinogenemia and fibrinogen deficiency, sponsored by Octapharma. Started Sep 2015; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital afibrinogenemiafibrinogen deficiency
Beyond the preview
Go deeper on IRCT2014112320051N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014112320051N3.